AIM Total Stockholder Equity from 2010 to 2024
| 0A4Y Stock | 0.22 0.01 4.35% |
Total Stockholder Equity | First Reported 2010-12-31 | Previous Quarter 70.5 M | Current Value 74 M | Quarterly Volatility 25.8 M |
Check AIM ImmunoTech financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among AIM ImmunoTech's main balance sheet or income statement drivers, such as Interest Income of 422.2 K, Interest Expense of 0.0 or Selling General Administrative of 8 M, as well as many indicators such as . AIM financial statements analysis is a perfect complement when working with AIM ImmunoTech Valuation or Volatility modules.
AIM | Total Stockholder Equity |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for AIM Stock Analysis
When running AIM ImmunoTech's price analysis, check to measure AIM ImmunoTech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AIM ImmunoTech is operating at the current time. Most of AIM ImmunoTech's value examination focuses on studying past and present price action to predict the probability of AIM ImmunoTech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AIM ImmunoTech's price. Additionally, you may evaluate how the addition of AIM ImmunoTech to your portfolios can decrease your overall portfolio volatility.